NIH-funded research NIH-funded research

Improving cancer detection using advanced DNA profiling techniques

Official title: Enriching and Base-Resolution Profiling of 5-Methylcytosine in Degraded Clinical Samples

Funded at University of Chicago · NIH-11064396 · Data updated 2026-11-12

This study is working on a new way to look at DNA changes related to cancer, using a special technique called Glimp-seq that can analyze tiny samples, like those from biopsies or blood tests, to help doctors detect cancer more accurately.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Chicago
NIH-funded
Lab location1 site (Chicago, United States)
Project startFebruary 1, 2025
Project endJanuary 31, 2028
Funding year2025
Award (this year)$230,010
NIH project number1R61CA297947-01
Project IDNIH-11064396 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with cancer or those at high risk of developing cancer, particularly if they have limited or degraded tissue samples available for analysis.

Less likely to help

Patients with early-stage cancer who have sufficient high-quality tissue samples may not benefit from this specific research focus.

What this research studies

This research focuses on enhancing the ability to profile 5-methylcytosine (5mC) in clinical samples, which is crucial for understanding and tracking cancer development. It aims to develop a new sequencing platform called Glimp-seq that can analyze degraded DNA from small samples, such as those found in formalin-fixed tissues and cell-free DNA. By utilizing innovative enzymatic reactions, this approach seeks to provide more accurate and sensitive detection of cancer-related changes in the DNA, potentially leading to better diagnostic methods.

Why it matters

Potential benefit: If successful, this research could lead to improved cancer detection methods, allowing for earlier diagnosis and better treatment options for patients.

How similar studies have gone: Previous research has shown promise in enhancing DNA profiling techniques, but this specific approach using glycosylase-based sequencing is novel and untested.

Where this research is happening

  • University of Chicago
    Chicago, United States
    Active

Researchers

  • Principal investigator: Tang, Weixin — University of Chicago
  • Study coordinator: Tang, Weixin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.